The p53 pathway in breast cancer
AUTOR(ES)
Gasco, Milena
FONTE
BioMed Central
RESUMO
p53 mutation remains the most common genetic change identified in human neoplasia. In breast cancer, p53 mutation is associated with more aggressive disease and worse overall survival. The frequency of mutation in p53 is, however, lower in breast cancer than in other solid tumours. Changes, both genetic and epigenetic, have been identified in regulators of p53 activity and in some downstream transcriptional targets of p53 in breast cancers that express wild-type p53. Molecular pathological analysis of the structure and expression of constituents of the p53 pathway is likely to have value in diagnosis, in prognostic assessment and, ultimately, in treatment of breast cancer.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=138723Documentos Relacionados
- Genetic basis for p53 overexpression in human breast cancer.
- Mutant p53 mediates survival of breast cancer cells
- P53 autoantibodies in 1006 patients followed up for breast cancer
- Mutations in p53 as potential molecular markers for human breast cancer.
- Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.